CD4 and neoplasm: A groundbreaking study from Devalaraja and colleagues provided a unifying theory by showing that tumor-expressed ALDH1a3 generates retinoic acid as a paracrine factor to activate tumor-associated macrophages and suppress CD4 T cell activity (Devalaraja et al., 2020).